Core Points - The company, Weitai Medical Devices (Hangzhou) Co., Ltd., has initiated a voluntary recall of its subcutaneous infusion sets for insulin pumps due to potential non-compliance with product technical requirements [1] - The recall is classified as a Class III recall, which indicates that the products involved do not pose a significant risk of injury or illness [1] - A total of 25,660 sets of the affected product, registered under the certificate number National Medical Device Approval 20173143333, were sold in China [1] Summary by Category - Product Recall - The company has proactively recalled the insulin pump subcutaneous infusion sets due to UV absorbance results that may not meet technical standards [1] - The recall is classified as Class III, indicating a lower risk level [1] - Sales Impact - The recall affects 25,660 units sold in the Chinese market [1] - Detailed information regarding the models, specifications, and batches of the recalled products is available in the Medical Device Recall Event Report [1]
微泰医疗器械（杭州）股份有限公司对胰岛素泵用皮下输液器主动召回